Literature DB >> 8938251

Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries.

T Nilsson1, L Cantera, L Edvinsson.   

Abstract

The neuropeptide Y-induced vasoconstriction of human cerebral arteries is mediated by the neuropeptide Y Y1 receptor. We conclude this on the basis of our results from: (1) in vitro studies on neuropeptide Y agonists. Neuropeptide Y and pro34NPY caused potent and long-lasting contractions of human cerebral arteries, while NPY 13-36 had no contractile effect at all on the vessels tested; (2) in vitro studies using the selective Y1 receptor antagonist BIBP3226 which in increasing concentrations (10(-9)-10(-6)M) caused a parallel shift to the right of the neuropeptide Y concentration-response curve without change of the maximum contractile response (pA2 value 8.38 +/- 0.10); and (3) with reverse transcriptase-polymerase chain reaction (RT-PCR) we detected specific mRNA for a neuropeptide Y Y1 receptor in human pial and human middle cerebral arteries using three forward primers and one reverse primer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938251     DOI: 10.1016/0304-3940(96)12315-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Localization of neuropeptide Y Y1 receptors in cerebral blood vessels.

Authors:  L Bao; J Kopp; X Zhang; Z Q Xu; L F Zhang; H Wong; J Walsh; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

3.  Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

Authors:  H Racchi; M J Irarrázabal; M Howard; S Morán; R Zalaquett; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

Authors:  H Gicquiaux; M Tschöpl; H N Doods; B Bucher
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Expression of Neuropeptide Y, Substance P, and their receptors in the right atrium of diabetic patients.

Authors:  Asma Ejaz; Frank W LoGerfo; Kamal Khabbaz; Leena Pradhan
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.